The long term outlook remains positive. Healthstream controls about 50% of the U.S. hospital market. That share is poised to keep expanding as more content providers are added and marketing efforts are enhanced. New products are rolling out. A joint venture with Norway based Laerdal Medical could provide substantial leverage. Ultimately, Healthsteam is well positioned to help the U.S. medical industry improve productivity through computerized instruction and other automation technologies. Expansion into related markets like surgery centers could reinforce growth. International opportunities provide further potential. The stock is trading at a high price in relation to earnings. But Healthstream remains a small company with key advantages in an enormous industry. Further appreciation is possible.
( Click on Table to Enlarge )